ATE98493T1 - Verwendung des rotavirus-nukleokapsid-vp6proteins in impfstoffzusammensetzungen. - Google Patents
Verwendung des rotavirus-nukleokapsid-vp6proteins in impfstoffzusammensetzungen.Info
- Publication number
- ATE98493T1 ATE98493T1 AT87307746T AT87307746T ATE98493T1 AT E98493 T1 ATE98493 T1 AT E98493T1 AT 87307746 T AT87307746 T AT 87307746T AT 87307746 T AT87307746 T AT 87307746T AT E98493 T1 ATE98493 T1 AT E98493T1
- Authority
- AT
- Austria
- Prior art keywords
- rotavirus
- nucleocapsid
- protein
- vaccine compositions
- carrier
- Prior art date
Links
- 241000702670 Rotavirus Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000001900 immune effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- -1 oligomer Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90322286A | 1986-09-03 | 1986-09-03 | |
| EP87307746A EP0259149B1 (de) | 1986-09-03 | 1987-09-02 | Verwendung des Rotavirus-Nukleokapsid-VP6-Proteins in Impfstoffzusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE98493T1 true ATE98493T1 (de) | 1994-01-15 |
Family
ID=25417135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87307746T ATE98493T1 (de) | 1986-09-03 | 1987-09-02 | Verwendung des rotavirus-nukleokapsid-vp6proteins in impfstoffzusammensetzungen. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0259149B1 (de) |
| JP (1) | JPS63218627A (de) |
| AT (1) | ATE98493T1 (de) |
| AU (1) | AU608769B2 (de) |
| CA (1) | CA1319101C (de) |
| DE (1) | DE3788475T2 (de) |
| DK (1) | DK171602B1 (de) |
| ES (1) | ES2060603T3 (de) |
| IE (1) | IE61417B1 (de) |
| IL (1) | IL83755A (de) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6086880A (en) * | 1985-12-26 | 2000-07-11 | The University Of Saskatchewan | Rotavirus peptide compositions and methods of use |
| CA1340530C (en) * | 1989-04-28 | 1999-05-04 | Kok Kheong Lee | Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
| GB9000143D0 (en) * | 1990-01-04 | 1990-03-07 | Natural Environment Res | Test kit and method for the diagnosis of bluetongue |
| US5298244A (en) * | 1990-10-25 | 1994-03-29 | University Of Saskatchewan | Assembled viral particles and their use in a vaccine to rotaviral disease |
| US5431899A (en) * | 1991-02-04 | 1995-07-11 | University Of Saskatchewan | Rotavirus VP6 as a diagnostic and targeting agent |
| DE69213030D1 (de) * | 1991-02-04 | 1996-09-26 | Univ Saskatchewan | Arzneistoffabgabe aus VP6-Kapseln |
| WO1994026306A1 (en) | 1993-05-12 | 1994-11-24 | Chiron Corporation | Conserved motif of hepatitis c virus e2/ns1 region |
| US5820868A (en) | 1993-12-09 | 1998-10-13 | Veterinary Infectious Disease Organization | Recombinant protein production in bovine adenovirus expression vector system |
| US6150137A (en) | 1994-05-27 | 2000-11-21 | Ariad Pharmaceuticals, Inc. | Immunosuppressant target proteins |
| US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
| DE19618797C2 (de) * | 1996-05-10 | 2000-03-23 | Bertling Wolf | Vehikel zum Transport molekularer Substanz |
| AU750702B2 (en) * | 1997-05-01 | 2002-07-25 | Chiron Corporation | Use of virus-like particles as adjuvants |
| WO1998059063A2 (en) | 1997-06-23 | 1998-12-30 | University Of Saskatchewan | Bovine adenovirus type 3 genome |
| DE19750354A1 (de) * | 1997-11-13 | 1999-05-27 | November Ag Molekulare Medizin | Verfahren zur Applikation von Wirkstoffen |
| US6492343B1 (en) | 1998-04-15 | 2002-12-10 | University Of Saskatchewan | Porcine adenovirus type 3 genome |
| DE19829005C2 (de) * | 1998-06-29 | 2000-08-31 | November Ag Molekulare Medizin | Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen |
| US6458586B1 (en) | 1998-11-02 | 2002-10-01 | University Of Saskatchewan | Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| MXPA01005389A (es) | 1998-11-30 | 2003-03-27 | Cytos Biotechnology Ag | Presentacion molecular ordenada de antigenos, metodos de preparacion y uso. |
| US6451319B1 (en) | 1999-04-09 | 2002-09-17 | Schering-Plough Veterinary Corporation | Recombinant and mutant adenoviruses |
| US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
| DE19916224C1 (de) | 1999-04-10 | 2000-06-21 | November Ag Molekulare Medizin | Synthetisches biologisch aktives Molekül |
| US7396905B1 (en) | 1999-05-21 | 2008-07-08 | Mckeon Frank | Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto |
| CA2356207C (en) | 1999-10-21 | 2012-10-09 | Case Western Reserve University | Gene expression profiling of inflammatory bowel disease |
| US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
| CA2407897A1 (en) | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
| AU6368901A (en) | 2000-05-31 | 2001-12-11 | Univ Saskatchewan | Modified bovine adenovirus having altered tropism |
| US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
| US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
| US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
| US7569217B2 (en) | 2001-09-24 | 2009-08-04 | University Of Saskatchewan | Porcine adenovirus E1 and E4 regions |
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| US7138252B2 (en) | 2002-07-17 | 2006-11-21 | Cytos Biotechnology Ag | Molecular antigen arrays |
| CA2487849A1 (en) | 2002-07-18 | 2004-01-29 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| AU2003255967A1 (en) | 2002-07-19 | 2004-02-09 | University Of Saskatchewan | Pav regions for encapsidation and e1 transcriptioonal control |
| EP2338510A1 (de) | 2002-07-19 | 2011-06-29 | Novartis Pharma AG | Impfstoffzusammensetzungen, die Amyloid-beta1-6 Antigen-Arrays enthalten |
| WO2004108939A2 (en) | 2003-06-10 | 2004-12-16 | University Of Saskatchewan | Bav packaging regions and e1 transcriptional control regions |
| ES2660341T3 (es) | 2004-08-26 | 2018-03-21 | The University Of Western Ontario | Dianas bacterianas de adquisición de hierro |
| US8999289B2 (en) | 2005-03-22 | 2015-04-07 | President And Fellows Of Harvard College | Treatment of protein degradation disorders |
| PE20061441A1 (es) | 2005-05-12 | 2007-01-18 | Novartis Ag | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia |
| WO2007059166A2 (en) | 2005-11-14 | 2007-05-24 | Weber Georg F | Peptide sequence that promotes tumor invasion |
| US8222423B2 (en) | 2006-02-14 | 2012-07-17 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
| US8304451B2 (en) | 2006-05-03 | 2012-11-06 | President And Fellows Of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
| KR20140120946A (ko) | 2007-08-03 | 2014-10-14 | 베링거 인겔하임 베트메디카 게엠베하 | 브라키스피라 하이오디센테리애의 유전자와 단백질 및 이의 용도 |
| GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| EP2363407A1 (de) | 2008-02-28 | 2011-09-07 | Murdoch University | Neuartige Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon |
| EP2271664A4 (de) | 2008-03-27 | 2011-11-23 | Prionics Ag | Neue sequenzen von brachyspira, immunogene zusammensetzung, herstellungsverfahren und anwendung davon |
| AU2009274549B2 (en) | 2008-07-23 | 2014-05-01 | Dana-Farber Cancer Institute, Inc. | Deacetylase inhibitors and uses thereof |
| WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
| CN111569056B (zh) * | 2020-05-26 | 2022-09-27 | 山东信得科技股份有限公司 | 一种猪轮状病毒疫苗、制备该疫苗的抗原及其编码序列 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0235391B1 (de) * | 1985-12-26 | 1992-06-10 | The University of Saskatchewan | Den antigenischen und immunogenischen Determinanten von wichtigen neutralisierenden Proteinen des Rotavirus entsprechende Peptide |
| US5186933A (en) * | 1986-12-30 | 1993-02-16 | Baylor College Of Medicine | Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
-
1987
- 1987-09-01 CA CA000545803A patent/CA1319101C/en not_active Expired - Fee Related
- 1987-09-02 IL IL83755A patent/IL83755A/xx not_active IP Right Cessation
- 1987-09-02 AT AT87307746T patent/ATE98493T1/de active
- 1987-09-02 IE IE235387A patent/IE61417B1/en not_active IP Right Cessation
- 1987-09-02 DE DE87307746T patent/DE3788475T2/de not_active Expired - Fee Related
- 1987-09-02 EP EP87307746A patent/EP0259149B1/de not_active Expired - Lifetime
- 1987-09-02 ES ES87307746T patent/ES2060603T3/es not_active Expired - Lifetime
- 1987-09-03 JP JP62221818A patent/JPS63218627A/ja active Pending
- 1987-09-03 AU AU77918/87A patent/AU608769B2/en not_active Ceased
- 1987-09-03 DK DK460387A patent/DK171602B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK171602B1 (da) | 1997-02-17 |
| DE3788475T2 (de) | 1994-04-07 |
| DK460387A (da) | 1988-03-04 |
| IE872353L (en) | 1988-03-03 |
| JPS63218627A (ja) | 1988-09-12 |
| IL83755A (en) | 1993-04-04 |
| CA1319101C (en) | 1993-06-15 |
| DK460387D0 (da) | 1987-09-03 |
| DE3788475D1 (de) | 1994-01-27 |
| IE61417B1 (en) | 1994-11-02 |
| ES2060603T3 (es) | 1994-12-01 |
| IL83755A0 (en) | 1988-02-29 |
| AU7791887A (en) | 1988-03-10 |
| EP0259149B1 (de) | 1993-12-15 |
| EP0259149A2 (de) | 1988-03-09 |
| EP0259149A3 (en) | 1989-05-24 |
| AU608769B2 (en) | 1991-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE98493T1 (de) | Verwendung des rotavirus-nukleokapsid-vp6proteins in impfstoffzusammensetzungen. | |
| DE59504181D1 (de) | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung | |
| MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
| FI895346A0 (fi) | Bindande proteiner. | |
| ATE47155T1 (de) | Monoklonaler antikoerper. | |
| RU94024561A (ru) | Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка | |
| FI874287A7 (fi) | Uudet lymfokiinipeptidit. | |
| ATE90384T1 (de) | Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder ''acquired immune deficiency syndrome'' (aids). | |
| CA2102301A1 (en) | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them | |
| DK0770679T3 (da) | HCV-specifikke peptider, præparater indeholdende dem og anvendelse deraf | |
| TR199700610A2 (xx) | D���k molek�l a��rl�kl� ��z�n�r, t�m�r nekroz fakt�r� tip-I ve tip-II proteinleri. | |
| NO854460L (no) | Syntetisk hepatitis-b-vaksine inbefattende baade t-celle og b-celledeterminanter. | |
| FI925043A0 (fi) | Varianta cd44-ytproteiner, dna-sekvenser som kodar foer dem, antikroppar mot dessa proteiner samt deras anvaendning i diagnos och terapi | |
| DE3854904D1 (de) | Peptide, die von der Faktor VIII-Bindungsdomäne des von Willebrand-Faktors abgeleitet sind | |
| ATE166231T1 (de) | Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen | |
| SE8601940D0 (sv) | Preparation of fused proteins, antibodies and processes therefor | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| IT1126709B (it) | Procedimento di candeggio ottico per substrati costituiti,in parte o in totalita',da poliammidi sintetiche | |
| GR3006212T3 (de) | ||
| DK628188D0 (da) | Protein og fremgangsmaade til fremstilling deraf | |
| SE9402253D0 (sv) | Process | |
| Sabara et al. | Rotavirus nucleocapsid protein VP6 in vaccine compositions | |
| DE69012328D1 (de) | Srif-verwandte peptide und deren verwendungen. | |
| NO873751L (no) | Lymfocytt-aktiverende polypeptider. |